Suppr超能文献

额颞叶痴呆综合征与帕金森症诊断标准的重叠。

Overlap in the diagnostic criteria of frontotemporal dementia syndromes with parkinsonism.

作者信息

Heikkinen Sami, Katisko Kasper, Haapasalo Annakaisa, Portaankorva Anne, Hartikainen Päivi, Solje Eino

机构信息

Institute of Clinical Medicine - Neurology, University of Eastern Finland, Kuopio, Finland.

A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.

出版信息

J Alzheimers Dis. 2025 Mar;104(2):374-381. doi: 10.1177/13872877251316804. Epub 2025 Feb 16.

Abstract

BackgroundDifferentiating neurodegenerative diseases can be difficult in the clinical setting. This study examines the overlap of diagnostic criteria between frontotemporal dementia (FTD) syndromes with parkinsonism [e.g., corticobasal syndrome (CBS), progressive supranuclear palsy (PSP), behavioral variant frontotemporal dementia (bvFTD)] and Parkinson's disease (PD).ObjectiveTo explore the diagnostic overlap in patients with FTD syndromes with parkinsonism and PD.MethodsPatient records from 2751 individuals at a tertiary neurological care center were reviewed, resulting in 112 bvFTD, 38 PSP, and 15 CBS patients. Clinical features and diagnostic criteria fulfillment were assessed.ResultsSignificant overlap in diagnostic criteria fulfilment was found: 42 bvFTD and 22 PSP patients met possible CBS criteria, 6 bvFTD patients met possible PSP criteria, and 4 met criteria for all three conditions. Higher cerebrospinal fluid levels of phosphorylated tau and tau were observed in the bvFTD group compared to PSP (p = 0.009, p = 0.002). The Mini-Mental State Examination score also differed between bvFTD and PSP (p = 0.020), and between PSP and CBS (p = 0.047). Neuroimaging showed substantial heterogeneity.ConclusionsThe study reveals significant overlap in diagnostic criteria among FTD syndromes with parkinsonism, underscoring the need for more precise diagnostic criteria. Improved biomarkers could support differential diagnosis and enhance clinical trial design. Common cerebrospinal fluid biomarkers used in Alzheimer's disease diagnostics may provide additional support in the differential diagnosis.

摘要

背景

在临床环境中,区分神经退行性疾病可能具有挑战性。本研究探讨了额颞叶痴呆(FTD)综合征伴帕金森综合征[如皮质基底节综合征(CBS)、进行性核上性麻痹(PSP)、行为变异型额颞叶痴呆(bvFTD)]与帕金森病(PD)之间诊断标准的重叠情况。

目的

探讨FTD综合征伴帕金森综合征患者与PD患者的诊断重叠情况。

方法

回顾了一家三级神经科护理中心2751名患者的病历,筛选出112例bvFTD、38例PSP和15例CBS患者。评估了临床特征和诊断标准的符合情况。

结果

发现诊断标准符合情况存在显著重叠

42例bvFTD和22例PSP患者符合可能的CBS标准,6例bvFTD患者符合可能的PSP标准,4例符合所有三种疾病的标准。与PSP相比,bvFTD组脑脊液中磷酸化tau和tau水平更高(p = 0.009,p = 0.002)。Mini - 精神状态检查评分在bvFTD和PSP之间(p = 0.020)以及PSP和CBS之间(p = 0.047)也存在差异。神经影像学显示出很大的异质性。

结论

该研究揭示了FTD综合征伴帕金森综合征之间诊断标准存在显著重叠,强调需要更精确的诊断标准。改进的生物标志物可以支持鉴别诊断并加强临床试验设计。用于阿尔茨海默病诊断的常见脑脊液生物标志物可能在鉴别诊断中提供额外支持。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验